Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein

doi:10.1084/jem.163.5.1191

This Article

	Full Text (PDF, 740K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Dale, J. B.
	Articles by Beachey, E. H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Dale, J. B.
	Articles by Beachey, E. H.


Social Bookmarking

	What's this?

ARTICLES

Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein

JB Dale and EH Beachey

We have used a set of overlapping chemically synthesized peptides representing the amino terminus of type 5 streptococcal M protein to localize protective, as opposed to nonprotective and tissue- crossreactive epitopes that might be appropriate for vaccine formulations. Rabbit antisera raised against SM5(1-35) reacted in high titer with pep M5 by ELISA and opsonized type 5 streptococci. None of the antisera crossreacted with human heart tissue or myosin. Antisera against SM5(26-35) reacted with SM5(1-35) and pep M5 but failed to opsonize type 5 streptococci. Particle-phase ELISA indicated that SM5(26-35) antibodies were directed against nonprotective determinants of pep M5 that were not exposed on the surface of viable organisms. Opsonization and ELISA inhibition assays showed that, of the SM5(1-35) antibodies that reacted with M5, all were inhibited by SM5(14-35), whereas none was inhibited by SM5(26-35), suggesting that the protective epitopes of SM5(1-35) resided between residues 14 and 26. This was confirmed by subsequent chemical synthesis of this region; SM5(14-26) totally inhibited SM5(1-35) antibodies that reacted with pep M5 in ELISA, and completely inhibited opsonization of type 5 streptococci by SM5(1-35) antibodies. SM5(14-26) evoked high titers of type-specific, opsonic antibodies against type 5 streptococci, confirming the protective immunogenicity of this 13-residue peptide of type 5 M protein.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Luca-Harari, B., Darenberg, J., Neal, S., Siljander, T., Strakova, L., Tanna, A., Creti, R., Ekelund, K., Koliou, M., Tassios, P. T., van der Linden, M., Straut, M., Vuopio-Varkila, J., Bouvet, A., Efstratiou, A., Schalen, C., Henriques-Normark, B., the Strep-EURO Study Group, , Jasir, A. (2009). Clinical and Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe. J. Clin. Microbiol. 47: 1155-1165 [Abstract] [Full Text]
McGregor, K. F., Spratt, B. G., Kalia, A., Bennett, A., Bilek, N., Beall, B., Bessen, D. E. (2004). Multilocus Sequence Typing of Streptococcus pyogenes Representing Most Known emm Types and Distinctions among Subpopulation Genetic Structures. J. Bacteriol. 186: 4285-4294 [Abstract] [Full Text]
Towers, R. J., Fagan, P. K., Talay, S. R., Currie, B. J., Sriprakash, K. S., Walker, M. J., Chhatwal, G. S. (2003). Evolution of sfbI Encoding Streptococcal Fibronectin-Binding Protein I: Horizontal Genetic Transfer and Gene Mosaic Structure. J. Clin. Microbiol. 41: 5398-5406 [Abstract] [Full Text]
Dale, J. B., Chiang, E. Y., Hasty, D. L., Courtney, H. S. (2002). Antibodies against a Synthetic Peptide of SagA Neutralize the Cytolytic Activity of Streptolysin S from Group A Streptococci. Infect. Immun. 70: 2166-2170 [Abstract] [Full Text]
Hu, M. C., Walls, M. A., Stroop, S. D., Reddish, M. A., Beall, B., Dale, J. B. (2002). Immunogenicity of a 26-Valent Group A Streptococcal Vaccine. Infect. Immun. 70: 2171-2177 [Abstract] [Full Text]
Kawabata, S., Kunitomo, E., Terao, Y., Nakagawa, I., Kikuchi, K., Totsuka, K.-i., Hamada, S. (2001). Systemic and Mucosal Immunizations with Fibronectin-Binding Protein FBP54 Induce Protective Immune Responses against Streptococcus pyogenes Challenge in Mice. Infect. Immun. 69: 924-930 [Abstract] [Full Text]
Guilherme, L., Cunha-Neto, E., Coelho, V., Snitcowsky, R., Pomerantzeff, P. M. A., Assis, R. V., Pedra, F., Neumann, J., Goldberg, A., Patarroyo, M. E., Pileggi, F., Kalil, J. (1995). Human Heart�Infiltrating T-Cell Clones From Rheumatic Heart Disease Patients Recognize Both Streptococcal and Cardiac Proteins. Circulation 92: 415-420 [Abstract] [Full Text]